ImmuneOncia Therapeutics, Inc. (KOSDAQ: A424870)
Health Care · Biotechnology · KR
₩3,300.00
-4.21% today · -46.3% 1Y
ImmuneOncia Therapeutics, Inc. (KOSDAQ: A424870) operates in the Biotechnology industry within the Health Care sector. The company is valued at $224.36M.
Over the last twelve months the share price has lost 46.3%, trading between 2.30K and 16.11K.
Tweenvest scores ImmuneOncia Therapeutics, Inc. across four factors: quality 39/100, value 40/100, growth 100/100. Its strongest factor is growth.
A424870 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $224.36M
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- -385.23
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩16,110.00
- 52-week low
- ₩2,300.00
- Avg volume (3M)
- —
- Shares outstanding
- 91.40M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ProQR Therapeutics N.V.NasdaqCM: PRQR | $230.03M | $1.68 | +3.07% |
| Valerio Therapeutics Société anonymeENXTPA: ALVIO | $229.28M | €0.41 | +7.61% |
| Spectral Medical Inc.TSX: EDT | $228.66M | CA$1.11 | -5.53% |
| Evommune, Inc.NYSE: EVMN | $226.83M | $6.06 | -3.04% |
| Protalix BioTherapeutics, Inc.NYSEAM: PLX | $223.99M | $2.78 | 0.00% |
| ToolGen IncorporatedKOSDAQ: A199800 | $223.81M | ₩33,450.00 | -3.18% |
| Akebia Therapeutics, Inc.NasdaqCM: AKBA | $221.99M | $0.80 | -0.32% |
| Sionna Therapeutics, Inc.NasdaqGM: SION | $221.54M | $4.71 | -3.88% |
Figures last refreshed Oct 11, 2026.